Name: HeartSciences Inc. (HSCS) Financial Statements
Creator: FinSpry

HeartSciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

HeartSciences Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2025	Apr 2024	Apr 2023	Apr 2022	Apr 2021
Revenue & Gross Profit
Revenue	0.00	0.02	0.01	0.01	0.03
Cost of Revenue	0.13	0.01	0.00	0.01	0.01
Gross Profit	-0.13	0.01	0.00	0.01	0.01
Operating Expenses
Research & Development	4.39	2.88	2.46	3.00	1.71
Selling, General & Administrative	3.84	3.44	3.65	1.71	0.87
Operating Expenses	8.23	6.32	6.12	4.72	2.58
Operating Income	-8.35	-6.31	-6.11	-4.71	-2.57
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00	0.00
Interest Expense	0.50	-0.35	0.24	-0.37	-0.13
Other Income/Expense	-0.41	0.05	0.00	0.00	0.00
Income
Income Before Tax	-8.77	-6.61	-6.35	-4.83	-2.45
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-8.77	-6.61	-6.35	-4.83	-2.45
Net Income - Continuous Operations	-8.77	-6.61	-6.35	-4.83	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-8.14	-6.28	-5.98	-4.68	-2.53
EBIT	-8.26	-6.31	-6.11	-4.71	-2.57
Depreciation & Amortization	0.13	0.03	0.14	0.03	0.03
Earnings Per Share
Basic EPS	-9.00	-19.00	-63.00	-145.00	-74.00
Diluted EPS	-9.00	-19.00	-63.00	-145.00	-74.00
Basic Shares Outstanding	0.94	0.35	0.10	0.03	0.03
Diluted Shares Outstanding	0.94	0.35	0.10	0.03	0.03